Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Geographic Revenue: Asia-Pacific & Other International by Year
Geographic Revenue: Asia-Pacific & Other International ($M, DB) ($M)
Natera Geographic Revenue: Asia-Pacific & Other International: $8.01M in FY2025, down 7.5% from a year earlier.
Latest, FY2025
8.01
Period ended Dec 31, 2025
Change on a year earlier
-7.5%
8.66 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Reported in Form 10-K/10-Q Geographic Footnote (DB).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Geographic Revenue: Asia-Pacific & Other International ($M, DB) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.01 | -7.5% | Form 10-K (2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 8.66 | +19.9% | Form 10-K (2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 7.22 | -48.5% | Form 10-K (2024-02-29) ↗ |
| FY2022 | Dec 31, 2022 | 14.0 | +38.4% | Form 10-K (2023-03-01) ↗ |
| FY2021 | Dec 31, 2021 | 10.1 | +34.5% | Form 10-K (2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 7.54 | -67.0% | Form 10-K (2021-02-26) ↗ |
| FY2019 | Dec 31, 2019 | 22.8 | +209.3% | Form 10-K (2020-03-02) ↗ |
| FY2018 | Dec 31, 2018 | 7.38 | +4.4% | Form 10-K (2019-03-15) ↗ |
| FY2017 | Dec 31, 2017 | 7.07 | -1.8% | Form 10-K (2019-03-15) ↗ |
| FY2016 | Dec 31, 2016 | 7.20 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Geographic Revenue: Asia-Pacific & Other International ($M), annual FY2016–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/db-seg-geo-other
See every metric in the Natera KPI table. Data updated Nov 2, 2026.